Regulatory Sourcebook eBook
Read the article:
Read the eBook:
Mapping Out Pharma’s Regulatory Future in Europe
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, Regulatory Sourcebook, September 2021
Volume 2021 eBook
Issue 3
Pages: 46–48
There are expectations that changes to pharma regulations in the EU, forming part of the regions broader strategy for the industry, will be positive and should offer flexibility for industry to advance through innovation.
MARTINA - STOCK.ADOBE.COM
In November 2020, the European Commission (EC) published its Pharmaceutical Strategy for Europe, which comprises four main objectives: affordable medicines access; support of the European Union’s pharma industry’s competitiveness, innovation, and sustainability; boosting crisis preparedness and response; and strengthening the EU’s global position in pharma. Additionally, as part of its broader strategy, the EC published its roadmap for revising pharmaceutical legislation in March 2021. Here, experts will discuss the strategy in greater detail and will also touch upon the potential for regulatory alignment between the European Union and United Kingdom post-Brexit.
Read in this article in Pharmaceutical Technology’s September 2021 Regulatory Sourcebook eBook.
Article Details
Pharmaceutical Technology
eBook: Regulatory Sourcebook
September 2021
Pages: 46–48
Citations
When referring to this article, please cite it as F. Thomas, “Mapping Out Pharma’s Future,” Pharmaceutical Technology’s Regulatory Sourcebook eBook (September 2021).
Articles in this issue
Understanding Combination Product Regulations
Considering Titanium Dioxide Regulatory Changes
The Real Danger of Substandard and Counterfeit COVID-19 Vaccines
Changing the Course of Drug Shortages
Sampling and Testing Nomenclature for Pharmaceutical Analysis: A Simplified Approach
Sampling and Testing Nomenclature for Pharmaceutical Analysis: A Review of Current Practices
Industry Organizations Assist Pharma During the Pandemic and Beyond
Mapping Out Pharma’s Regulatory Future in Europe
Recent Videos
Related Content
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024Article
This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
